Translocations, fusion genes, and acute leukemia

Journal of Cellular Biochemistry

Volumn , Issue SUPPL. 30/31, 1998, Pages 264-276

  Saha, Vaskar ^a,c   Young, Bryan D ^a   Freemont, Paul S ^b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b Lab of Molec Struct and Function   (United Kingdom)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LEUKEMIA; APOPTOSIS; ARTICLE; CHROMOSOME TRANSLOCATION; FUSION GENE; GENE EXPRESSION REGULATION; GENE FUSION; GENE LOCATION; HUMAN; LEUKEMOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; TRANSCRIPTION REGULATION; ACUTE DISEASE; ANIMAL; BIOLOGICAL MODEL; GENE TRANSLOCATION; GENETICS; LEUKEMIA; PATHOLOGY; PHYSIOLOGY; REVIEW; TUMOR GENE;

MAMMALIA;

ACUTE DISEASE; ANIMALS; GENES, NEOPLASM; HUMANS; LEUKEMIA; MODELS, BIOLOGICAL; TRANSLOCATION, GENETIC;

EID: 0032428639     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-4644(1998)72:30/31+<264::aid-jcb32>3.3.co;2-l     Document Type: Article

References (25)

1. Adler HT, Nallaseth FS, Walter G, Tkachuk DC (1997): HRX leukemic fusion proteins form a heterocomplex with the leukemia-associated protein SET and protein phosphatase 2A. J Biol Chem 272:28407-28414.
2. Akasaka T, Tsuji K, Kawahira H, Kanno M, Harigaya K, Hu L, Ebihara Y, Nakahata T, Tetsu O, Taniguchi M, Koseki H (1997): The role of mel-18, a mammalian Polycomb group gene, during IL-7-dependent proliferation of lymphocyte precursors. Immunity 7:135-146.
3. Altura RA, Inukai T, Ashmun RA, Zambetti GP, Roussel MF, Look AT (1998): The chimeric E2A-HLF transcription factor abrogates p53-induced apoptosis in myeloid leukaemia cells. Blood 92:1397-1405.
4. Arakawa H, Nakamura T, Zhadanov AB, Fidanza V, Yano T, Bullrich F, Shimizu M, Blechman J, Mazo A, Canaani E, Croce CM (1998): Identification and characterization of the ARP1 gene, a target for the human acute leukemia ALL1 gene. Proc Natl Acad Sci USA 95:4573-4578.
5. Barr FC (1998): Translocations, cancer and the puzzle of specificity. Nature Genet 19:121-124.
6. Biernaux C, Loos M, Sels A, Huez G, Stryckmans P (1995): Detection of major BCR-ABL gene expression at a very low level in blood cells of some healthy individuals. Blood 86:3118-3122.
7. Bonnet D, Dick JE (1997): Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med 3:730-737.
8. Brehm A, Miska EA, McCance D J, Reid JL, Bannister AJ, Kouzarides T (1998): Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391: 597-601.
9. Brown JL, Mucci D, Whiteley M, Dirksen M-L, Kassis JA (1998): The Drosophila polycomb group gene pleihomeotic encodes a DNA binding protein with homology to the transcription factor YY1. Mol Cell 1:1057-1064.
10. Butler LH, Slany R, Cui X, Cleary ML, Mason DY (1997): The HRX proto-oncogene product is widely expressed in human tissues and localizes to nuclear structures. Blood 89:3361-3370.
11. Castilla LH, Wijmenga C, Wang Q, Stacy T, Speck NA, Eckhaus M, Marin-Padilla M, Collins FS, Wynshaw-Boris A, Liu PP (1996): Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell 87:687-696.
12. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y, Evans RM (1997): Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90:569-580.
13. Core N, Bel S, Gaunt SJ, Aurrand-Lions M, Pearce J, Fisher A, Djabali M (1997): Altered cellular proliferation and mesoderm patterning in Polycomb-M33-deficient mice. Development 124:721-729.
14. Corral J, Lavenir I, Impey H, Warren AJ, Forster A, Larson TA, Bell S, McKenzie AN, King G, Rabbitts TH (1996): An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: A method to create fusion oncogenes. Cell 85:853-861.
15. Cui X, De Vivo I, Slany R, Miyamoto A, Firestein R, Cleary ML (1998): Association of SET domain and myotubularin-related proteins modulates growth control. Nature Genet 18:331-337.
16. De Vivo I, Cui X, Domen J, Cleay ML (1998): growth stimulation of primary B-cell precursors by the antiphosphatase Sbf1. Proc Natl Acad Sci USA 95:9471-9476.
17. Fears S, Gavin M, Zhang DE, Hetherington C, Ben-David Y, Rowley JD, Nucifora G (1997): Functional characterization of ETV6 and ETV6/CBFA2 in the regulation of the MCSFR proximal promoter. Proc Natl Acad Sci USA 94:1949-1954.
18. Gale KB, Ford AM, Repp R, Borkhardt A, Keller C, Eden OB, Greaves MF (1997): Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA 94:13950-13954.
19. Golub TR, Barker GF, Stegmaier K, Gilliland DG (1997): The TEL gene contributes to the pathogenesis of myeloid and lymphoid leukemias by diverse molecular genetic mechanisms. Curr Top Microbiol Immunol 220:67-79.
20. Gould A (1997): Functions of mammalian Polycomb group and trithorax group related genes. Curr Opin Genet Dev 7:488-494.
21. Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Peschle C, Nicoletti I, et al. (1993): The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74:423-431.
22. Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrar FF, Zamir I, Seiser C, Lazar MA, Minucci S, Pelicci PG (1998): Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 391: 815-818.
23. Grunstein M (1997): Histone acetylation in chromatin structure and transcription. Nature 389:349-352.
24. Hess JL, Yu BD, Li B, Hanson R, Korsmeyer SJ (1997): Defects in yolk sac hematopoiesis in Mll-null embryos. Blood 90:1799-806.
25. Hodges M, Tissot C, Howe K, Grimwade D, Freemont PS (1998): Stucture, organisation and dynamics of PML nuclear bodies. Am J Hum Genet 63:297-304.